Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: Early outcome results

Wisconsin Medical Journal

Volumn 95, Issue 12, 1996, Pages 867-871

  Murdock, David K ^a,b   Hoffman, Mark T ^a   Logemann, Timothy N ^a   Kaufman, Jay S ^a   Engelmeier, Richard S ^a  

^a Aspirus Wausau Hospital   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; PROTAMINE SULFATE; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; STENT; SURVIVAL RATE; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030479693     PISSN: 00436542     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679.
2. Lee TC, Laramee LA, Rutherford BD, et al. Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. Am J Cardiol 1990; 66:663-667.
3. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. JAm Coll Cardiol 1995; 25:370-377.
4. Laster SB, Rutherford BD, Giorgi LV, et al. Results of Direct Purcutaneous Transluminal Coronary Angioplasty in Octogenarians. Am J Cardiol 1996; 77:10-13.
5. DeBoer MJ, Hoontje JCA, Ottervanger JP, et al. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994; 23:1004-1008.
6. de Feyter PJ, van den Brand M, Jaarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management and follow-up. Circulation 1991; 83:927-936.
7. Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profle. J AM Coll Cardiol 1992; 19:926-935.
8. Simonton CA, Mark DB, Hinohara T, et al. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: Comparison with elective angioplasty. J AM Coll Cardiol 1988; 11:698-705.
9. Brodie BR, Grines CL, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Circulation 1994; 25:156-162.
10. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85:916-927.
11. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316:701 -706.
12. Serruys PW, de Jaegere P, Kiemeneij F, et al. for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. New Engl J Med 1994; 331:489495.
13. Fischman DL, Leon MB, Bairn DS, et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement in balloon angioplasty in the treatment of coronary artery disease. New Engl J Med 1994; 331 :496-501.
14. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 1991; 324:13-17.
15. Walton AS, Oesterie, SN, Yeung AC. Coronary artery stenting for acute closure complication primary angioplasty for acute myocardial infarction. Cath & Cardiovasc Diag 1995; 34:142-148.
16. Steinhubl SR, Moliterno DJ, Teirstein PS, et al. Stenting for acute myocardial infarction: the early United States multicenter experience 1996;27:279A (abstract).
17. Neumann FJ, Walter H, Schmitt C, et al. Coronary stenting as an adjuvant to direct balloon angioplasty in acute myocardial infarction. Circulation 1995;92:2916 (abstract).
18. Leung L, Nachman R. Molecular mechanisms of platelet aggregation. Annu Rev Med 1986; 37:179-186.
19. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322:3342.
20. Collar BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76:101-108.
21. Tcheng JE, Ellis SG, George BS, et al. Pharmacodynamics of chimeric Glycoprotein IIb/IIIa integrin antiplatelet antibody fate 7E3 in high-risk coronary angioplasty. Circulation 1994; 90:1757-1764.
22. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330:956-961.
23. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985; 312:932-936.
24. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral ASA, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2:349-360.
25. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. The randomized IABP study group. Circulation 1994; 90:792-799.
26. Toprol EJ, Califf RM, Weisman H, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343:881-886.